Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Otto Energy Ltd. | O1E | Nov 25, 2024 | 0.01 | +122.22 |
OUE Limited | OUE1 | Nov 25, 2024 | 0.69 | 0.00 |
Ourgame International Holdings Limited | 13O | Nov 25, 2024 | 0.02 | 0.00 |
Outbrain Inc | 852 | Nov 25, 2024 | 4.84 | -0.82 |
Outfront Media Inc | 76C | Nov 25, 2024 | 18.20 | 0.00 |
Outlook Therapeutics | 41O | Nov 25, 2024 | 4.50 | -6.64 |
Outokumpu | OUTA | Nov 25, 2024 | 3.19 | +0.38 |
OUTSURANCE GROUP LTD. | RMQ0 | Nov 25, 2024 | 3.32 | -0.60 |
Ovation Science Inc Common Shares (Canada) | 0VH | Nov 25, 2024 | 0.01 | +8.33 |
Ovb Holding | O4B | Nov 25, 2024 | 20.00 | +0.50 |
Oversea-chinese Banking Corp | OCBB | Nov 25, 2024 | 23.00 | 0.00 |
Oversea-Chinese Banking Corporation Limited | OCBA | Nov 25, 2024 | 11.72 | -0.68 |
Overstock.com, Inc. | OVER | Nov 25, 2024 | 5.39 | +2.28 |
OVH Groupe | 7U7 | Nov 25, 2024 | 8.14 | +0.56 |
OVH GROUPE UNSP.ADR/1/2 | 7U70 | Nov 25, 2024 | 3.52 | -0.57 |
Ovid Therapeutics Inc. | 1OT | Nov 25, 2024 | 0.96 | -1.03 |
Ovintiv Inc. (DE) | 47Q | Nov 25, 2024 | 44.31 | +0.29 |
Ovs SPA | 0OV1 | Nov 25, 2024 | 2.75 | +3.38 |
Ovzon | OVZ | Nov 25, 2024 | 1.10 | -11.90 |
Owens & Minor, Inc. | 6OM | Nov 25, 2024 | 12.20 | +4.27 |
Owens Corning Inc | O5Q | Nov 25, 2024 | 197.20 | +4.45 |
Owl Rock Capital Corporation | 1D6 | Nov 25, 2024 | 14.47 | -0.08 |
OXE Marine | 5LK | Nov 25, 2024 | 0.00 | +120.00 |
Oxford BioDynamics plc | LMQ | Nov 25, 2024 | 0.00 | 0.00 |
Oxford Biomedica | OXOA | Nov 25, 2024 | 5.05 | +2.64 |
Oxford Industries, Inc. | OXD | Nov 25, 2024 | 75.50 | +2.03 |
Oxford Instruments PLC | OX3 | Nov 25, 2024 | 24.80 | 0.00 |
Oxford Lane Capital Corp. | 4RQ | Nov 25, 2024 | 4.97 | +0.56 |
Oxford Lane Capital Corp. - 6.25% Series 2027 Term Preferred | 4RQ0 | Nov 25, 2024 | 22.60 | -0.88 |
Oxford Metrics plc | RNI | Nov 25, 2024 | 0.74 | +0.68 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.